Lipid and Cholesterol Metabolism Flashcards
Outline the pro-atherogenic effects of OX-LDL
Inhibits macrophage motility
Induces T-cell activation and VSMC division / differentiation
Toxic to endothelial cells
Enhances platelet aggregation
How is cholesterol synthesised?
In the liver
Starts with acetyl-CoA
Requires HMG-CoA synthase and reductase
Recognise the main drug groups used in reducing LDL cholesterol
Statins = simvastatin
Cholesterol lipase inhibitors = ezetimibe
Nicotinic acid / niacin
Fibrates = fenofibrate
Resins = colestyramine
Omega-3 FA = omacor
Discuss statins
Inhibit cholesterol synthesis in hepatocytes = block HMG-CoA reductase
Increase clearance of IDL and LDL – make sure receptors are still valid
Decrease production of VLDL and LDL
What are the indication for the use of statins?
CV risk prevention (CVD + DM)
Familial hypercholesterolaemia
What are the adverse side effects of statins?
Liver damage - increased transaminase levels
Myopathy – pains in joints and muscles
Name some secondary benefits of statin treatment
Anti-inflam
Plaque reduction
Improved endothelial cell function
Reduced thrombotic risk
Describe fibric acid derivatives
Mechanism = increases prod of lipoprotein lipase = reduces TG prod, SMALL reduction in LDL
Indication = adjunctive to diet, hypertriglyceridemia
ADR = GI upset, myositis, abnormal LFTs
Describe nicotinic acid
Mechanism = inhib lipoprotein a synthesis = reduced VLDL, increases HDL
Indication = risk of coronary events
ADR = flushing (taken with aspirin), itching, headache, hepatotoxicity
Describe ezetimibe?
Mechanism = inhibits intestinal cholesterol absorption, increase hepatic LDL receptors
ADR = headache, abdo pain, diarrhoea
Describe evolocumab
Monoclonal Ab
PCSK9 inhibitor = inhibits proprotein convertase
Treats primary hypercholesterolaemia or mixed dyslipidaemia as adjunct to diet
Recognise the potential for non-drug dietary approaches to lipid lowering
Good diet has great impact on TG
Plant sterols – yogurts, flora
Diet rich in = fish oils, fibres, vit C/E
outline how to undertake a CV risk assessment
QRISK2
Age
Gender
Ethnicity
Postcode
Clinical info = smoking, DM, angina, CDK, AF, BP treatment, RA
Outline the NICE guidance pertaining to lipid-lowering drug prescribing
Statin - recommend as primary prevention of CVD for adults who have a 20% or greater 10 year risk of devel CVD